Skip to main content
Search
Main content
Profile picture of Henrik Zetterberg

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

Alzheimer's & dementia : the journal of the Alzheimer's Association
Published
Choroidal-ventricular system abnormalities are linked to amyloid-β aggregation in Alzheimer's disease
Authors
Seyyed Ali Hosseini, Etienne Aumont, Nesrine Rahmouni, Marcel S Woo, Arthur C Macedo, Brandon Hall, Tevy Chan, Joseph Therriault, Lydia Trudel, Yansheng Zheng, Gleb Bezgin, Aurélie Lebrun, Jaime Fernandez Arias, Kely Quispialaya Socualaya, Cécile Tissot, Stijn Servaes, Yi-Ting Wang, Delphine Oliva-Lopez, Stuart Mitchell, Robert Hopewell, Chris Hung-Hsin Hsiao, Catherine Saleh, Jenna Stevenson, Firoza Lussier, Liyong Wu, Min Chu, Sanjeev Chawla, Vladimir Fonov, Gassan Massarweh, Yasser Iturria Medina, Jean-Paul Soucy, Karine Provost, David A Rudko, Thomas Karikari, Andréa Lessa Benedet, Nicholas J Ashton, Henrik Zetterberg, Maxime Montembeault, Paolo Vitali, Kaj Blennow, Serge Gauthier, D Louis Collins, Jesse Klostranec, Tharick A Pascoal, Pedro Rosa-Neto
Choroidal-ventricular system abnormalities are linked to amyloid-β aggregation in Alzheimer's disease
The Lancet. Neurology
Published
A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA
Authors
Eric M Reiman, Robert C Alexander, Jessica B Langbaum, Paul S Aisen, Nicholas Ashton, Alireza Atri, Paola Barbarino, Goldie S Byrd, Howard H Feldman, Nicole R Fowler, Valentina Ghisays, Joshua D Grill, Jason Hassenstab, George R Heaton, William L Herring, Clifford R Jack, Sterling C Johnson, Jason Karlawish, Nancy L Keach, Miia Kivipelto, Harlan M Krumholz, Emily A Largent, Tamiko MaGee-Rodgers, Eric McDade, Michelle M Mielke, Doris Molina-Henry, Ronald C Petersen, Gil D Rabinovici, Craig Ritchie, Suzanne E Schindler, Reisa A Sperling, Marc Suárez-Calvet, George Vradenburg, Michael W Weiner, Kathleen A Welsh-Bohmer, Henrik Zetterberg, Michael T Zuendel, Soeren Mattke, Jeffrey L Cummings
A path to preventing cognitive impairment due to Alzheimer's disease: initiatives beginning in the USA
npj aging
Published
Unraveling the role of polyamine metabolism in postoperative delirium: insights into biochemical mechanisms and biomarker potential
Authors
Nazia Saiyed, Vaibhav Pandya, Xiaobei Pan, Miroslava Cuperlovic-Culf, Nadia Ashrafi, Shiva Kant, Marie Migaud, Jyothi Dhuguru, Henrik Zetterberg, Bernadette McGuinness, Anthony P Passmore, Leiv Otto Watne, Brian D Green, Emma L Cunningham, Stewart F Graham
Unraveling the role of polyamine metabolism in postoperative delirium: insights into biochemical mechanisms and biomarker potential
Alzheimer's & dementia : the journal of the Alzheimer's Association
Published
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET
Authors
Ashvini Keshavan, Katharine Wiltshire, Ryan Wee, Irene Gorostiaga Belio, Katie Tucker, Melanie Hart, Michael P Lunn, Michael C B David, Laura Rizzo, Omid Sadeghi-Alavijeh, Patricia Wilson, Daniel P Gale, Amanda J Heslegrave, Henrik Zetterberg, Nick C Fox, Paresh Malhotra, Jonathan M Schott
The Alzheimer's Disease Diagnosis and Plasma Phospho-Tau217 (ADAPT) study stage 1: Validating clinical cut-points against CSF and amyloid PET

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia